LOS ANGELES, Nov. 26, 2025 /PRNewswire/ — In a breakthrough that combines privacy, cryptographic integrity and intelligent automation, a purpose-built…
NEW YORK, Nov. 26, 2025 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies…
CAMBRIDGE, Mass., Nov. 26, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically…